The percentage of CD68-positive cells in the bone marrow nucleated cell number was significantly increased in patients with HHH than in patients without HHH (25.2 % ± 20.0 % vs. 12.1 % ± 4.0 %, p < 0.001) (Fig. 2). The gene discussed is CD68; the disease is ornithine translocase deficiency.